Small Business Innovation Research Phase IIB Bridge Awards

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health, otherwise known as NIH, is an agency that is operating within the Department of Health and Human Services.

The National Institutes of Health is the United States government's principal agency that is responsible for most of the country's biomedical and health-related research studies.

The mission of the NIH is to continuously obtain new information that would help prevent, detect, diagnose, and treat diseases and disabilities.

In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

The program is in conjunction with the long running Small Business Innovation Research (SBIR) Program of NIH. The purpose of the SBIR program is to facilitate the innovation of solutions to existing health challenges by aiding the commercialization of the technologies that have been developed by small business concerns.

(continued...)

Small Business Innovation Research Phase IIB Bridge Awards
Page 2

About The Author

The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs.

The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program

The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

Pilot Studies of Innovative Treatments in Mental Disorders Project

The National Institutes of Health has recently collaborated with the National Institutes of Mental Health (NIMH) to establish the Pilot Studies of Innovative Treatments in Mental Disorders Program.

Development of Therapeutics and Diagnostics for Biodefense Program

The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

Small Business Innovation Research Phase IIB Bridge Awards